Filter Results:
(467)
Show Results For
- All HBS Web
(1,624)
- Faculty Publications (467)
Show Results For
- All HBS Web
(1,624)
- Faculty Publications (467)
- November 2019
- Teaching Note
Hacking Heroin
By: Mitchell Weiss and Sarah Mehta
This teaching note pairs with a case that is used in a course on Public Entrepreneurship, for a first module on "ideas." The case is designed to help students work through the question: where do new ideas to stubborn problems come from? And, in particular, the question... View Details
- May 2019 (Revised February 2022)
- Background Note
The Gig Economy: Leasing Skills to Pay the Bills
By: Joseph Fuller, William R. Kerr and Carl Kreitzberg
This primer provides a comprehensive exploration into the gig economy and how it is reshaping global business. It shows how the Uber driver, the freelancing programmer in India, and the independent corporate consultant are all different variants of the modern-day gig... View Details
Keywords: Gig Economy; COVID-19 Pandemic; Talent and Talent Management; Human Resources; Labor; Strategy; Management; Globalization; North America; Europe; United States; United Kingdom
Fuller, Joseph, William R. Kerr, and Carl Kreitzberg. "The Gig Economy: Leasing Skills to Pay the Bills." Harvard Business School Background Note 819-146, May 2019. (Revised February 2022.)
- February 2018 (Revised March 2018)
- Case
ArcelorMittal and the Ebola Outbreak in Liberia
By: Sophus A. Reinert, Sarah Nam, Sisi Pan and Eric Werker
During the summer of 2014, Alan Knight, general manager of corporate responsibility at the integrated steel and mining company ArcelorMittal, observed the unfolding of an Ebola epidemic in Liberia and other countries in West Africa with great concern. On the one hand... View Details
Keywords: Ebola; Epidemics; Ebola Private Sector Mobalization Group; EPSMG; Civil War; Sovereignty; Change Management; Judgments; Development Economics; Geopolitical Units; Globalized Firms and Management; Emerging Markets; Business and Community Relations; Business and Government Relations; Safety; War; Wealth and Poverty; Welfare; Crisis Management; Mining Industry; Liberia
Reinert, Sophus A., Sarah Nam, Sisi Pan, and Eric Werker. "ArcelorMittal and the Ebola Outbreak in Liberia." Harvard Business School Case 718-029, February 2018. (Revised March 2018.)
- August 2017
- Case
Hacking Heroin
By: Mitchell Weiss and Sarah Mehta
"Hacking Heroin" was the first hackathon that Annie Rittgers, founder of Cincinnati-based 17a, had organized or even attended. "There will continue to be a lot of preventable overdose deaths and wasted potential if the opioid crisis continues unabated," she said.... View Details
Keywords: Public Entrepreneurship; Hackathon; Heroin; Opioids; Crowdsourcing; Public Sector; Entrepreneurship; Innovation and Invention; Collaborative Innovation and Invention; Health Pandemics; Public Administration Industry; Health Industry; Ohio; Cincinnati
Weiss, Mitchell, and Sarah Mehta. "Hacking Heroin." Harvard Business School Case 818-010, August 2017.
- 2017
- Casebook
Public Health Preparedness: Case Studies in Policy and Management
By: Arnold M. Howitt, Dutch Leonard and David W. Giles
This book provides detailed accounts of a range of public health emergencies. Topics range from natural disasters, to infectious diseases, to pandemics, and more. With chapters on Superstorm Sandy, H1N1, the Ebola virus, and bioterrorism, these cases cover major areas... View Details
Keywords: Health Care and Treatment; Health Pandemics; Natural Disasters; Safety; Public Sector; Policy; Management
Howitt, Arnold M., Dutch Leonard and David W. Giles, eds. Public Health Preparedness: Case Studies in Policy and Management. Washington, DC: American Public Health Association, 2017.
- May 20, 2016
- Comment
World Health Organization Lacks Leadership to Combat Pandemics
By: John A. Quelch
When it comes to emergency preparedness for pandemics, the World Health Organization is falling short. It has not provided prompt and clear leadership to the world in combating either the Ebola or Zika viruses. Its leadership has been low energy, its representatives... View Details
Keywords: Global Health; World Health Organization; World Bank; Pandemics; Emergency Preparedness; Experience and Expertise; Decisions; Forecasting and Prediction; Communication Strategy; Nonverbal Communication; Framework; Governance; Government and Politics; Health; Management; Practice; Problems and Challenges; Projects; Risk and Uncertainty; Human Needs; Civil Society or Community; Social Issues; Welfare or Wellbeing; Biotechnology Industry; Health Industry; Journalism and News Industry; Medical Devices and Supplies Industry; Public Administration Industry; Tourism Industry; Transportation Industry; Travel Industry; Africa; Asia; Europe; Latin America; North and Central America; South America; West Indies
Quelch, John A. "World Health Organization Lacks Leadership to Combat Pandemics." Harvard Business School Working Knowledge (May 20, 2016).
- January–February 2015
- Article
Heroic Villains: Are Foreign Investors Problems or Solutions in the Ebola Crisis?
By: Debora L. Spar
For months, the news out of West Africa has been unrelentingly grim. As of early December, the devastating Ebola epidemic had infected a reported 17,942 people and killed 6,388, according to the World Health Organization (WHO); the actual toll, which would also account... View Details
Keywords: Ebola; Multinational Corporation; Epidemics; Foreign Investment; Extractive Industries; Multinational Firms and Management; Health Pandemics; Developing Countries and Economies; Government and Politics; Africa
Spar, Debora L. "Heroic Villains: Are Foreign Investors Problems or Solutions in the Ebola Crisis?" Foreign Policy 210 (January–February 2015).
- May 2014 (Revised January 2015)
- Case
Vaxess Technologies, Inc.
By: John A. Quelch and Margaret L. Rodriguez
In February 2014, Michael Schrader, chief executive of Vaxess Technologies, Inc., was assessing the startup health care company's 2014 marketing plan. On December 31st, 2013, Vaxess had obtained an exclusive license to a series of patents for a silk protein technology... View Details
Keywords: Vaccine; Cold Chain; Antigen; Temperature Controlled; Developing Markets; Immunization; Health Care and Treatment; Health Pandemics; Global Strategy; Supply Chain; Health; Health Industry; Medical Devices and Supplies Industry
Quelch, John A., and Margaret L. Rodriguez. "Vaxess Technologies, Inc." Harvard Business School Case 514-107, May 2014. (Revised January 2015.)
- March 2009
- Teaching Note
Sex, Drugs, and Rock 'n Roll: The MTV Approach to Tackling HIV/AIDS (TN)
By: Tarun Khanna, Sonali R. Bloom and David E. Bloom
Teaching Note for [709429]. View Details
- June 2008
- Supplement
PSI India -- Will Balbir Pasha Help Fight AIDS? (A) and (B), Supporting Video
By: Elie Ofek
Ofek, Elie. "PSI India -- Will Balbir Pasha Help Fight AIDS? (A) and (B), Supporting Video." Harvard Business School Video Supplement 508-708, June 2008.
- May 2008
- Teaching Note
Disney Consumer Products: Marketing Nutrition to Children (TN)
By: David E. Bell and Mary L. Shelman
Teaching Note for [507-006]. View Details
- February 2007
- Supplement
PSI India -- Will Balbir Pasha Help Fight AIDS? (B)
By: Elie Ofek
Ofek, Elie. "PSI India -- Will Balbir Pasha Help Fight AIDS? (B)." Harvard Business School Supplement 507-058, February 2007.
- January 2006 (Revised July 2006)
- Case
Drug Testing in Nigeria (A)
By: Debora L. Spar
In 1996, a meningitis epidemic swept across Nigeria. Thousands of children were struck and, lacking appropriate medicine, were liable to die from the disease. Doctors at Pfizer had an antibiotic that could probably save most of these children's lives. The drug was new,... View Details
Keywords: Risk and Uncertainty; Health Pandemics; Health Testing and Trials; Developing Countries and Economies; Pharmaceutical Industry; Nigeria
Spar, Debora L., and Adam Day. "Drug Testing in Nigeria (A)." Harvard Business School Case 706-033, January 2006. (Revised July 2006.)
- July 2002 (Revised December 2002)
- Case
Phase Two: The Pharmaceutical Industry Responds to AIDS
By: Debora L. Spar
Describes how major pharmaceutical firms changed their strategy and pricing policies in the years 2000 to 2002 to respond to the growing AIDS epidemic in Africa. View Details
Keywords: International Finance; Health Pandemics; Corporate Social Responsibility and Impact; Pharmaceutical Industry; Africa
Spar, Debora L., and Nick Bartlett. "Phase Two: The Pharmaceutical Industry Responds to AIDS." Harvard Business School Case 703-005, July 2002. (Revised December 2002.)
- June 2002 (Revised November 2005)
- Case
Life, Death, and Property Rights: The Pharmaceutical Industry Faces AIDS in Africa
By: Debora L. Spar
In the final years of the 20th century, the world was hit by a plague of epidemic proportions--AIDS, a life-threatening disease that remained stubbornly immune to any cure or vaccine. In the developed nations of the West, AIDS was slowly brought under control through a... View Details
Keywords: Patents; Health Pandemics; Corporate Social Responsibility and Impact; Pharmaceutical Industry; Africa
Spar, Debora L., and Nick Bartlett. "Life, Death, and Property Rights: The Pharmaceutical Industry Faces AIDS in Africa." Harvard Business School Case 702-049, June 2002. (Revised November 2005.)
- November 1999
- Supplement
"ACT UP": Peter Staley, An Interview with Professor Willis Emmons, November 17, 1995
Provides excerpts from an interview with Peter Staley of Act Up reflecting on the Wall Street protest against Burroughs Wellcome in the fall of 1989 and on the role and impact of AIDS advocacy and activism in general. View Details
Emmons, Willis M., III. "ACT UP": Peter Staley, An Interview with Professor Willis Emmons, November 17, 1995. Harvard Business School Video Supplement 700-501, November 1999.
- July 1997
- Case
Technology Crisis and the Future of Agribusiness: Antibiotic Resistance in Humans and Animals
By: Ray A. Goldberg and Juan Enriquez-Cabot
Goldberg, Ray A., and Juan Enriquez-Cabot. "Technology Crisis and the Future of Agribusiness: Antibiotic Resistance in Humans and Animals." Harvard Business School Case 598-024, July 1997.
- March 1993
- Supplement
Burroughs Wellcome and AZT (B)
Describes Burroughs Wellcome's response to protests over the pricing of its AIDS drug AZT in September 1989. Also presents short-term reactions by government officials, AIDS activists, and investors to Burroughs Wellcome's strategy. View Details
Keywords: Ethics; Health Pandemics; Multinational Firms and Management; Price; Crime and Corruption; Risk and Uncertainty; Business Strategy; Business and Community Relations; Business and Government Relations; Business and Shareholder Relations; Pharmaceutical Industry
Emmons, Willis M., III. "Burroughs Wellcome and AZT (B)." Harvard Business School Supplement 793-114, March 1993.
- March 1993
- Supplement
Burroughs Wellcome and AZT (C)
Describes key developments relating to Burroughs Wellcome, AZT and other AIDS drugs, and the AIDS issue in general from late 1989 through 1992. Includes excerpts from Wellcome PLC's financial statements and updated statistics on AIDS in the United States. View Details
Keywords: Health Pandemics; Multinational Firms and Management; Financial Statements; Pharmaceutical Industry; United States
Emmons, Willis M., III. "Burroughs Wellcome and AZT (C)." Harvard Business School Supplement 793-115, March 1993.
- November–December 1991
- Article
The Case of AIDS
By: R. S. Tedlow and M. Marram
Keywords: Health Pandemics
Tedlow, R. S., and M. Marram. "The Case of AIDS." Harvard Business Review 69, no. 6 (November–December 1991): 14–20.